ZAZA ANTONIO

Badone, B., Ronchi, C., Lodola, F., Maniezzi, C., Eskandr, M., Florindi, C., et al. (2022). SERCA2a gain of function in patient-derived R14Del hiPSC-CMs. THE JOURNAL OF GENERAL PHYSIOLOGY, 154(9) [10.1085/jgp.2021ecc3]. Dettaglio

Luraghi, A., Ferrandi, M., Barassi, P., Arici, M., Hsu, S., Torre, E., et al. (2022). Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure. JOURNAL OF MEDICINAL CHEMISTRY, 65(10), 7324-7333 [10.1021/acs.jmedchem.2c00347]. Dettaglio

Zaza, A., Lodola, F. (2021). Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome. CIRCULATION RESEARCH, 129(6), 666-668 [10.1161/CIRCRESAHA.121.319851]. Dettaglio

Ronchi, C., Bernardi, J., Mura, M., Stefanello, M., Badone, B., Rocchetti, M., et al. (2021). NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis. CARDIOVASCULAR RESEARCH, 117(2 (1 February 2021)), 472-483 [10.1093/cvr/cvaa036]. Dettaglio

Lee, Y., Sala, L., Mura, M., Rocchetti, M., Pedrazzini, M., Ran, X., et al. (2021). MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes. CARDIOVASCULAR RESEARCH, 117(3 (1 March 2021)), 767-779 [10.1093/cvr/cvaa019]. Dettaglio